Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020022368> ?p ?o ?g. }
- W2020022368 endingPage "611" @default.
- W2020022368 startingPage "597" @default.
- W2020022368 abstract "SH2 domains are attractive targets for chemotherapeutic agents due to their involvement in the formation of protein-protein interactions critical to many signal transduction cascades. Little is known, however, about how synthetic SH2 domain ligands would influence the growth properties of tumor cells or with which intracellular proteins they would interact due to their highly charged nature and enzymatic lability. In this study, a prodrug delivery strategy was used to introduce an enzymatically stable, phosphotyrosine peptidomimetic into tumor cells. When tested in a human tumor cell panel, the prodrug exhibited a preference for inhibiting the growth of leukemia and lymphoma cells. In these cells, it was largely cytostatic and induced endoreduplication and the appearance of midbodies. Proteomic analyses identified multiple targets that included mitotic centromere-associated kinesin (MCAK). Molecular modeling studies suggested the ATP-binding site on MCAK as the likely site of drug interaction. Consistent with this, ATP inhibited the drug-MCAK interaction and the drug inhibited MCAK ATPase activity. Accordingly, the effects of the prodrug on the assembly of the mitotic spindle and alignment of chromosomes were consistent with the identification of MCAK as an important intracellular target." @default.
- W2020022368 created "2016-06-24" @default.
- W2020022368 creator A5008101786 @default.
- W2020022368 creator A5019299889 @default.
- W2020022368 creator A5030313910 @default.
- W2020022368 creator A5032308142 @default.
- W2020022368 creator A5034497116 @default.
- W2020022368 creator A5040900629 @default.
- W2020022368 creator A5045225071 @default.
- W2020022368 creator A5047884786 @default.
- W2020022368 creator A5056368645 @default.
- W2020022368 creator A5088027601 @default.
- W2020022368 creator A5090421697 @default.
- W2020022368 date "2013-09-01" @default.
- W2020022368 modified "2023-09-27" @default.
- W2020022368 title "Intracellular targets for a phosphotyrosine peptidomimetic include the mitotic kinesin, MCAK" @default.
- W2020022368 cites W1886278373 @default.
- W2020022368 cites W1972130810 @default.
- W2020022368 cites W1972364945 @default.
- W2020022368 cites W1985588649 @default.
- W2020022368 cites W1989627660 @default.
- W2020022368 cites W2000473242 @default.
- W2020022368 cites W2004854804 @default.
- W2020022368 cites W2005778309 @default.
- W2020022368 cites W2015556811 @default.
- W2020022368 cites W2021721410 @default.
- W2020022368 cites W2026271132 @default.
- W2020022368 cites W2026465178 @default.
- W2020022368 cites W2027062351 @default.
- W2020022368 cites W2030540334 @default.
- W2020022368 cites W2032733101 @default.
- W2020022368 cites W2033406586 @default.
- W2020022368 cites W2034341688 @default.
- W2020022368 cites W2035277099 @default.
- W2020022368 cites W2036388423 @default.
- W2020022368 cites W2039520479 @default.
- W2020022368 cites W2048415203 @default.
- W2020022368 cites W2052938668 @default.
- W2020022368 cites W2053437486 @default.
- W2020022368 cites W2055102703 @default.
- W2020022368 cites W2071698219 @default.
- W2020022368 cites W2072364504 @default.
- W2020022368 cites W2074113529 @default.
- W2020022368 cites W2076814468 @default.
- W2020022368 cites W2087312216 @default.
- W2020022368 cites W2089950231 @default.
- W2020022368 cites W2092401565 @default.
- W2020022368 cites W2092782214 @default.
- W2020022368 cites W2093272109 @default.
- W2020022368 cites W2102377211 @default.
- W2020022368 cites W2107913178 @default.
- W2020022368 cites W2110944043 @default.
- W2020022368 cites W2111645250 @default.
- W2020022368 cites W2112078820 @default.
- W2020022368 cites W2112597950 @default.
- W2020022368 cites W2143174721 @default.
- W2020022368 cites W2147339550 @default.
- W2020022368 cites W2171581152 @default.
- W2020022368 cites W2951124894 @default.
- W2020022368 cites W2952920474 @default.
- W2020022368 cites W4249839795 @default.
- W2020022368 doi "https://doi.org/10.1016/j.bcp.2013.06.024" @default.
- W2020022368 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3755495" @default.
- W2020022368 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23830822" @default.
- W2020022368 hasPublicationYear "2013" @default.
- W2020022368 type Work @default.
- W2020022368 sameAs 2020022368 @default.
- W2020022368 citedByCount "4" @default.
- W2020022368 countsByYear W20200223682014 @default.
- W2020022368 countsByYear W20200223682015 @default.
- W2020022368 countsByYear W20200223682023 @default.
- W2020022368 crossrefType "journal-article" @default.
- W2020022368 hasAuthorship W2020022368A5008101786 @default.
- W2020022368 hasAuthorship W2020022368A5019299889 @default.
- W2020022368 hasAuthorship W2020022368A5030313910 @default.
- W2020022368 hasAuthorship W2020022368A5032308142 @default.
- W2020022368 hasAuthorship W2020022368A5034497116 @default.
- W2020022368 hasAuthorship W2020022368A5040900629 @default.
- W2020022368 hasAuthorship W2020022368A5045225071 @default.
- W2020022368 hasAuthorship W2020022368A5047884786 @default.
- W2020022368 hasAuthorship W2020022368A5056368645 @default.
- W2020022368 hasAuthorship W2020022368A5088027601 @default.
- W2020022368 hasAuthorship W2020022368A5090421697 @default.
- W2020022368 hasBestOaLocation W20200223682 @default.
- W2020022368 hasConcept C108215921 @default.
- W2020022368 hasConcept C145226528 @default.
- W2020022368 hasConcept C1491633281 @default.
- W2020022368 hasConcept C185592680 @default.
- W2020022368 hasConcept C20418707 @default.
- W2020022368 hasConcept C29537977 @default.
- W2020022368 hasConcept C47432576 @default.
- W2020022368 hasConcept C55493867 @default.
- W2020022368 hasConcept C59006786 @default.
- W2020022368 hasConcept C79879829 @default.
- W2020022368 hasConcept C85813293 @default.
- W2020022368 hasConcept C86803240 @default.
- W2020022368 hasConcept C93304396 @default.
- W2020022368 hasConcept C95444343 @default.